US BANCORP \DE\ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 191 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$66,110
+49.6%
11,578
+31.3%
0.00%
Q1 2024$44,188
-50.7%
8,820
-11.6%
0.00%
Q4 2023$89,702
+30.9%
9,978
+13.1%
0.00%
Q3 2023$68,531
-19.7%
8,8200.0%0.00%
Q2 2023$85,378
-16.8%
8,820
-5.8%
0.00%
Q1 2023$102,574
+169.2%
9,359
+6.1%
0.00%
Q4 2022$38,102
-42.3%
8,8200.0%0.00%
Q3 2022$66,000
-25.8%
8,8200.0%0.00%
Q2 2022$89,000
-18.3%
8,8200.0%0.00%
Q1 2022$109,000
-46.0%
8,8200.0%0.00%
Q4 2021$202,0000.0%8,820
-3.2%
0.00%
Q3 2021$202,000
+71.2%
9,1080.0%0.00%
Q2 2021$118,000
+0.9%
9,108
+1.0%
0.00%
Q1 2021$117,000
-4.1%
9,020
+2.3%
0.00%
Q4 2020$122,000
-6.2%
8,8200.0%0.00%
Q3 2020$130,000
-9.1%
8,8200.0%0.00%
Q2 2020$143,000
+11.7%
8,8200.0%0.00%
Q1 2020$128,000
-28.5%
8,8200.0%0.00%
Q4 2019$179,000
+280.9%
8,8200.0%0.00%
Q3 2019$47,000
-19.0%
8,8200.0%0.00%
Q2 2019$58,000
+1.8%
8,8200.0%0.00%
Q1 2019$57,000
-5.0%
8,8200.0%0.00%
Q4 2018$60,000
-34.8%
8,820
-36.2%
0.00%
Q3 2018$92,00013,8200.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Abingworth LLP 400,434$2,655,0001.58%
NEA Management Company, LLC 4,808,483$31,928,0001.38%
Kazazian Asset Management, LLC 170,356$1,131,0001.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 212,865$1,413,0000.99%
Vivo Capital, LLC 1,213,290$8,056,0000.81%
Polar Capital LLP 2,811,516$18,668,0000.16%
Cutler Capital Management, LLC 55,000$254,0000.11%
Patriot Financial Group Insurance Agency, LLC 20,000$133,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 77,913$517,0000.05%
MGO ONE SEVEN LLC 11,000$73,0000.03%
View complete list of AURINIA PHARMACEUTICALS INC shareholders